Drug interactions between daratumumab and Revlimid
Interactions between your drugs
There were no interactions found in our database between daratumumab and Revlimid - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Daratumumab is in the drug class CD38 monoclonal antibodies.
- Daratumumab is used to treat Multiple Myeloma.
- Revlimid is a member of the following drug classes: miscellaneous antineoplastics, other immunosuppressants.
- Revlimid is used to treat the following conditions:
Drug and food interactions
No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.